Effect of tirofiban-assisted transradial approach to direct percutaneous coronary intervention on the treatment of myocardial infarction and its impact on hospitalization time
Objective To investigate the effect of tirofiban-assisted transradial approach to direct percutaneous coronary intervention on the treatment of myocardial infarction and its impact on hospitalization time. Methods A total of 78 patients with myocardial infarction treated in Tianjin Nankai Hospital from May 2014 to May 2017 were randomly divided into study group and control group, 39 cases in each group. The two groups received transradial approach to direct percutaneous coronary intervention, while the control group received anticoagulant and anti platelet aggregation drugs, the study group was given tirofiban on the basis of the control group.The main outcome events (new myocardial infarction, death, post infarction angina pectoris) and hospitalization time were recorded in two groups of patients with myocardial infarction. Results The incidence of postinfarction angina pectoris and composite end point in the study group was significantly lower than that in the control group (P<0.05). The average hospitalization time of the study group was (21.03±1.06) d, the average hospitalization time of the control group was (26.14±1.79) d, the difference was statistically significant (P<0.05). Conclusion The effect of tirofiban-assisted transradial approach to direct percutaneous coronary intervention in patients with myocardial infarction is significant, which can effectively reduce the incidence of major end events and shorten hospital stay.
myocardial infarctionradial artery pathwaypercutaneous coronary interventiontirofibanhospitalization time
NETL
NSTL
万方数据
维普
